Table 5 Odds of primary and secondary outcomes in validation cohort based on ED-SAS score

30-day Mortality

4.4 (1.8–10.8)

12.0 (4.9–29.4)

41.7 (15.8–110.1)

180-day Mortality

3.1 (1.8–5.4)

6.1 (3.4–10.9)

14.8 (7.3–30.1)

Acute kidney injury

2.0 (1.6–2.6)

3.3 (2.4–4.5)

5.6 (3.4–9.3)

Respiratory failure

2.9 (1.6–4.9)

5.7 (3.1–10.3)

7.6 (3.3–17.2)

Sepsis

2.9 (1.7–5.0)

7.2 (4.1–12.7)

17.1 (8.5–34.3)

ICU Admission

2.3 (1.5–3.5)

3.1 (1.9–5.0)

4.6 (2.3–9.3)